Our startups

50% of overweight & obese individuals suffer from Metabolic Syndrome in which there is a chronic elevation of blood Insulin levels, which in turn increases Insulin Resistance, causing an increase in appetite and over-eating, thus creating a vicious cycle, causing MI & Strokes.
We will cut off this vicious cycle by inhibiting Insulin secretion using a Somatostatin analogue, reverse Metabolic Syndrome, lower body weight & prevent pre-diabetic patients from developing type 2 diabetes.